Skip to content
Natera

Medical Director - Skin/IO

US Remote; USRemote · United States
Director+ · Medical Affairs - Oncology
POSTED 20 JANVERIFIED 5H AGO
Apply Ask
Role
303 days opentrue age
Past the 33d median close
Posted 20 Jan · n=112
Payats field
$262k–327kposted
▲ +40% vs market median $210k
$94k$327k
Market p25–p75
$165k–$255k
Natera p25–p75
$178k–$257kn=25
H-1B median · Other
$94k
United States · n=6405 · 365d to 19 Nov
CompanyNatera →
204open roles
Opened · 30d
+80
Closed · 30d
−90
Signal
● Steady−10 net
19d of snapshots · 30d window
Market
25,401open · Director+ Other
Opened · 7d
+2,74811% of open
All other
621,964open
All tracked boards · live 20 Nov · n=25,401
Visa
48H-1B LCAs · FY26
PERM · FY26
7
Median wage
$132k
LCAs FY26 · n=48 · to 2026-06-29

Location: Remote with ~40% domestic and international travel

Shape the future of cancer care as a Medical Director, Skin/IO at Natera. In this strategic leadership role, you will provide medical expertise and scientific leadership across Natera’s oncology portfolio, with a focus on melanoma, cutaneous malignancies, and immunotherapy applications across solid tumors. You will collaborate with cross-functional teams in research, development, medical affairs, and commercial functions to ensure the scientific integrity and clinical adoption of Natera’s oncology testing solutions.

Primary Responsibilities

Clinical Adoption

  • Lead the clinical strategy and evidence generation for melanoma, non-melanoma skin cancers, and pan-tumor immunotherapy indications.
  • Partner closely with clinical development, medical affairs, and commercial teams to translate emerging evidence into meaningful clinical practice applications.
  • Collaborate with key opinion leaders (KOLs), cooperative groups, and academic investigators to validate and expand clinical use cases for ctDNA-based diagnostics in immuno-oncology.
  • Provide field-facing education and strategic guidance to healthcare providers, payers, and advocacy organizations on clinical utility, interpretation, and impact of MRD and response monitoring in immune-treated populations.
  • Identify and address barriers to adoption by aligning evidence generation, messaging, and stakeholder engagement with evolving standards of care and health system needs.

Medical Education and Communication

  • Serve as the medical and scientific spokesperson for skin and immuno-oncology programs, communicating clinical utility, study data, and product value to external experts and stakeholders.
  • Partner with commercial teams to develop educational resources, medical content, and scientific training for healthcare providers and internal teams.
  • Provide scientific leadership during advisory boards, symposia, and investigator meetings.

Representation and Advocacy

  • Represent Natera at national and international oncology and immunotherapy conferences, fostering relationships with key opinion leaders in melanoma and IO.
  • Promote a culture of scientific rigor and innovation within the medical affairs and R&D organizations.

Research and Development

  • Collaborate on clinical trial design, data analysis, and publication strategy related to ctDNA applications in melanoma and other immune-responsive solid tumors.
  • Identify and cultivate academic and cooperative group partnerships to advance clinical validation and translational research in skin and pan-tumor immuno-oncology.

Key Skill Sets / Responsibilities

Skin and Immuno-Oncology Expertise

  • Deep clinical knowledge of melanoma and cutaneous oncology, including evolving standards of care, targeted therapy, and checkpoint inhibitor use.
  • Expertise in immunotherapy mechanisms, response kinetics, and biomarker development across multiple solid tumor types.
  • Provide expert medical guidance on immunotherapy-specific diagnostic development and clinical implementation.

Comprehensive Oncology Knowledge

  • Ability to engage across tumor types to support Natera’s broad oncology portfolio.
  • Maintain awareness of emerging trends in liquid biopsy, precision medicine, and immune response monitoring.

Cross-Disciplinary Collaboration

  • Work collaboratively with research, development, commercial, and medical affairs to align medical strategy with business objectives.
  • Partner with regulatory and clinical operations teams to ensure compliance, data quality, and clinical relevance.

Qualifications

  • MD. or D.O. degree with board certification in Medical Oncology (required).
  • At least 5 years of experience in oncology, with clinical or research experience in melanoma, skin cancers, or immunotherapy (preferred).
  • Strong publication or clinical trial background in immuno-oncology or translational oncology research (preferred).
  • Associate or full Medical Director designation commensurate with experience.

Knowledge, Skills, and Abilities

  • Ability to rapidly learn Natera’s molecular testing technologies and apply clinical judgment to evaluate and communicate their relevance.
Source · NateraFirst seen 2 NovOriginal ↗